DOCSLIB.ORG

2 0 1 5 a N N U a L R E P O

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2 0 1 5 a N N U a L R E P O 2015 ANNUAL REPORT FINANCIAL OPERATING HIGHLIGHTS (Dollars in Millions Except Per Share Data and Number of Associates) 2015 2014 Sales* $ 20,563.1 $ 19,154.0 Operating Profit* $ 3,469.1 $ 3,346.6 Net Earnings * $ 2,598.7 $ 2,543.1 Net Earnings Per Share (diluted) * $ 3.67 $ 3.56 Operating Cash Flow* $ 3,828.0 $ 3,618.0 Capital Expenditures* $ 633.0 $ 580.6 Free Cash Flow $ 3,195.0 $ 3,037.4 (Operating Cash Flow less Capital Expenditures) * Number of Associates 81,000 71,000 Total Assets $ 48,222.2 $ 36,991.7 Total Debt ** $ 12,870.4 $ 3,473.4 Stockholders’ Equity $ 23,764.0 $ 23,449.8 Total Capitalization $ 36,634.4 $ 26,923.2 (Total Debt plus Stockholders’ Equity) * From Continuing Operations ** Long-Term Debt ($12,025.2 for 2015 and $3,401.5 for 2014) plus Notes Payable and Current Portion of Long-Term Debt ($845.2 for 2015 and $71.9 for 2014) Environmental Our products help protect the global water supply, facilitate environmental stewardship, enhance the safety of personal data and improve business efficiencies. Our Water Quality platform provides instrumentation and disinfection systems to help analyze, treat and manage the quality of ultra-pure, potable, waste, ground and ocean water in residential, commercial, industrial and natural resource applications. Our Gilbarco Veeder-Root platform is a leading worldwide provider of solutions and services focused on fuel dispensing, remote fuel management, point-of-sale and payment systems, environmental compliance, vehicle tracking and fleet management. With a lightweight, compact and rugged design, the Surveyor HL and Hydrolab HL4 from OTT Hydromet, a division of Hach, help environmentalists measure a variety of water quality parameters in real-time, or for continuous unattended monitoring. Test & Measurement Our essential products, software and services help our customers create actionable intelligence through measurement and monitoring. We offer test, measurement and monitoring products that are used in the design and development of electronic, industrial, video and other advanced technologies and components, as well as for installation, service and maintenance of electrical, industrial, electronic and calibration applications. We also manufacture and distribute professional tools, toolboxes and automotive diagnostic equipment for professional mechanics through a network of franchised mobile distributors. With over 20 different wireless test tools and software, Fluke Connect helps engineers identify and diagnose problems quickly and confidently, while securely sharing critical data in the cloud—all without leaving the field. Industrial Technologies Our solutions help protect the world’s food supply, improve packaging design and quality, verify pharmaceutical dosages and authenticity, and power innovative machines. Our Product Identification platform develops and manufactures equipment, consumables and software for various printing, marking, coding, design and color management applications on consumer and industrial products. Our Automation platform provides electromechanical and electronic motion control solutions and mechanical components for the industrial automation market and various precision motion applications. A unique set of 3D design, communication and visualization tools, Esko’s Studio helps packaging design professionals produce artwork on a variety of packaging materials. Life Sciences & Diagnostics We are at the leading edge of scientific research and development, and advancing patient health with high diagnostic confidence. Our Diagnostics platform offers analytical instruments, reagents, consumables, software and services that hospitals, physician’s offices, reference laboratories and other critical care settings use to diagnose disease, monitor and guide treatment and therapy, assist in managing chronic disease and assess patient status. Our Life Sciences platform offers a broad range of research tools that scientists use to study the basic building blocks of life in order to understand the causes of disease, identify new therapies, and test new drugs and vaccines. With the addition of Pall, we are also a leading provider of filtration, separation and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics and general industrial markets. The Aperio LV1 is Leica Biosystems’ real-time, live view digital pathology system for researchers new to digital pathology. Its intuitive interface, small footprint, minimal IT requirements and versatility help research laboratories deliver results faster. Dental We enable a broad spectrum of dental professionals, from general dentists and specialists to lab techs and university students, to provide high level of patient care and confidently optimize their work environments. Our products are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as improve the aesthetics of the human smile. We are a leading worldwide provider of a broad range of dental consumables, equipment and services, and are dedicated to driving technological innovations that help dental professionals improve clinical outcomes and enhance productivity. The DEXIS Platinum Sensor and DEXIS Eleven Imaging Suite aid dental practitioners in diagnosing problems and planning treatment by providing highly detailed images, automated workflow features, easy-to-use imaging tools and cloud-based storage options. DEAR SHAREHOLDERS, 2015 was an extraordinary year for Danaher. We completed the largest acquisition in our history with Pall Corporation, announced the pending launch of Fortive Corporation, and drove excellent overall financial results. Despite a challenging economic backdrop, Danaher continued to execute well and create shareholder value. n We generated more than $20 billion in revenue, with $5.5 billion in the high growth markets, including over $2 billion in China alone. n The growth tools of the Danaher Business System (DBS) helped us continue to build our competitive advantage and gain market share across a number of operating companies. n We achieved more than 8% year-over-year Adjusted Diluted Net Earnings Per Share growth – among the best in our peer set. n We generated a record $3.2 billion in free cash flow, one of the best indicators of our execution quality. Our free cash flow to net income conversion ratio was 123%, the 24th consecutive year in which our free cash flow has exceeded net income. n We deployed more than $14 billion in acquisition related THOMAS P. JOYCE, JR. capital, announcing or completing 13 transactions, President and Chief Executive Officer in addition to Pall, with each of our five business segments executing at least one acquisition. While Danaher today is larger than it was a year ago, our goal is not exclusively to build a bigger Danaher, but to build a better Danaher. Perhaps the most significant affirmation of this goal was our announcement in May to establish a new industrial growth company, Fortive Corporation, which we expect to launch in the third quarter of 2016. Following the separation, Danaher will be a $16 billion multi-industry, science and technology growth company, well positioned to grow organically, improve profitability, deploy capital and generate substantial earnings growth for our shareholders. DBS will remain the core of our operating model, the cornerstone of our culture and the foundation upon which we build our competitive advantage. We expect Danaher’s market-leading brands to benefit from favorable secular growth trends, while generating high recurring revenues and gross margins with lower overall cyclicality. Our portfolio will include Danaher’s current Life Sciences, Diagnostics, Dental, Water Quality and Product Identification platforms, and Pall. EXECUTING ON OUR 2015 PRIORITIES Optimizing Our Portfolio To complement our focused organic initiatives, we continued Danaher delivered outstanding overall financial results in 2015 our strategic approach to capital allocation. Our acquisition by focusing our businesses on three strategic priorities: of Pall Corporation exemplifies how we continue to add important and highly strategic operating companies to Enhancing Our Competitive Position with DBS Danaher’s portfolio. DBS is our ultimate competitive advantage. It empowers us with the tools and processes to drive improvement Pall is a leading global provider in all aspects of our business. Using DBS growth tools, of filtration, separation and we strengthened our competitive advantage and gained purification solutions used share across a number of operating companies, including to remove contaminants or ChemTreat, Qualitrol, Gilbarco Veeder-Root, Hach, SCIEX, separate substances from Radiometer and Matco Tools. a variety of solids, liquids and gases. Decades of work At Matco, advancements by the company’s filtration in our transformative engineers and scientists have marketing initiative enabled Pall to build a globally generated a record number respected business that customers rely on to help solve of new franchise leads their most difficult filtration and purification problems across in 2015. The thoughtful a broad spectrum of high-growth life sciences and industrial implementation of DBS applications. Pall filters are used in the discovery, development tools, such as Transactional and production of biological drugs, vaccines, cell therapies and Process Improvement, other pharmaceuticals, and have additional applications in the further enhanced Matco’s microelectronics, aerospace, fuels,
Load more

Recommended publications
  • 2019 Annual Report
    1984 2019 2019 MARKED DANAHER’S 35TH ANNIVERSARY To honor this milestone, the front cover of this year's annual report features the original Danaher logo and bright blue color palette. We proudly celebrate our company's history as the prelude to a 35 future filled with opportunity. By living our core values of building the best team, continuously improving, “ listening to our customers every day and driving innovation, we ultimately deliver long-term shareholder value.” Thomas P. Joyce, Jr. Financial Operating Highlights (dollars in millions except per share data and number of associates) 2019 2018 Sales $ 17,911.1 $ 17,048.5 Operating Profit $ 3,269.4 $ 3,055.1 Net Earnings $ 2,432.3 $ 2,406.3 Net Earnings Per Share (diluted) $ 3.26 $ 3.39 Operating Cash Flow $ 3,657.4 $ 3,644.0 Investing Cash Flow $ (1,166.1) $ (2,873.9) Financing Cash Flow $ 16,589.9 $ (797.4) Capital Expenditures $ (635.5) $ (583.5) Capital Disposals $ 12.8 $ 6.3 Free Cash Flow (Operating Cash Flow less Capital Expenditures plus Capital Disposals) $ 3,034.7 $ 3,066.8 Number of Associates 60,000 58,000 Total Assets* $ 62,081.6 $ 47,832.5 Total Debt ** $ 21,729.1 $ 9,740.3 Stockholders’ Equity $ 30,281.9 $ 28,226.7 Total Capitalization (Total Debt plus Stockholders’ Equity) $ 52,011.0 $ 37,967.0 * 2018 data includes both continuing and discontinued operations ** Long-Term Debt ($21,516.7 for 2019 and $9,688.5 for 2018) plus Notes Payable and Current Portion of Long-Term Debt ($212.4 for 2019 and $51.8 for 2018) All financial data set forth in this annual report relates solely to continuing operations unless otherwise indicated.
    [Show full text]
  • 2017 INVESTOR & ANALYST DAY December 14, 2017
    2017 INVESTOR & ANALYST DAY December 14, 2017 Forward Looking Statements Statements in this presentation that are not strictly historical, including any statements regarding events or developments that we believe or anticipate will or may occur in the future are "forward-looking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things, deterioration of or instability in the economy, the markets we serve and the financial markets, contractions or growth rates and cyclicality of markets we serve, competition, our ability to develop and successfully market new products and technologies and expand into new markets, the potential for improper conduct by our employees, agents or business partners, our compliance with applicable laws and regulations (including regulations relating to medical devices and the health care industry), our ability to effectively address cost reductions and other changes in the health care industry, our ability to successfully identify, consummate and integrate appropriate acquisitions and successfully complete divestitures and other dispositions, our ability to integrate the recent acquisitions of Pall Corporation and Cepheid and achieve the anticipated benefits of such transactions, contingent
    [Show full text]
  • 2010 Annual Report
    2010 ANNUAL REPORT Segmentation Voice of the Customer Dynamic Resource Allocation Brand Management Policy Deployment MEASURING Risk Management Value Selling Innovation Talent SUCCESS Accelerated Product Development Sales Force Initiatives Emerging Markets Digital Marketing DBS 2010 ANNUAL REPORT In 2010, Danaher updated reporting segments to reflect the evolution of our business to a science and technology company. We now report results in five business segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental; and Industrial Technologies. TEST & MEASUREMENT Our Test & Measurement segment is a leading, global provider of electronic measurement instruments and monitoring, management and optimization tools for communications and enterprise networks and related services. Our products are used in the design, development, manufacture, installation, deployment and operation of electronics equipment and communications networks and services. Customers for our products and services include manufacturers of electronic instruments; service, installation and maintenance professionals; network equipment manufacturers who design, develop, manufacture and install network equipment and service providers who implement, maintain and manage communications networks and services. Also included in our Test & Measurement segment are our mobile tool and wheel service businesses. Financial Operating Highlights 2010 2009 (dollars in thousands except per share data and number of associates) Sales $ 13,202,602 $ 11,184,938 Operating profit
    [Show full text]
  • Journal 2428
    Iris um Oifig Maoine Intleachtúla na hÉireann Journal of the Intellectual Property Office of Ireland Iml. 96 Cill Chainnigh 06 January 2021 Uimh. 2428 CLÁR INNSTE Cuid I Cuid II Paitinní Trádmharcanna Leath Leath Official Notice 1 Official Notice 1 Applications for Patents 3 Applications for Trade Marks 3 Patents Granted 4 Oppositions under Section 43 68 European Patents Granted 5 Application(s) Withdrawn 68 Applications Withdrawn, Deemed Withdrawn or Trade Marks Registered 69 Refused 151 Trade Marks Renewed 69 Request for Grant of Supplementary Protection Application(s) for Leave to Alter Registered Certificate 167 Trade Mark(s) 71 Supplementary Protection Certificate Withdrawn 168 Leave to Alter Registered Trade Mark(s) Supplementary Protection Certificate Rejected 168 Granted 71 Application for Extension of the Duration of a International Registrations under the Madrid Supplementary Protection Certificate 169 Protocol 72 Errata 170 International Trade Marks Protected 93 Cancellations effected for the following goods/services under the Madrid protocol 95 Dearachtaí Designs Information under the 2001 Act Designs Registered 171 The Journal of the Intellectual Property Office of Ireland is published fortnightly. Each issue is freely available to view or download from our website at www.ipoi.gov.ie © Rialtas na hÉireann, 2021 © Government of Ireland, 2021 1 (06/01/2021) Journal of the Intellectual Property Office of Ireland (No. 2428) Iris um Oifig Maoine Intleachtúla na hÉireann Journal of the Intellectual Property Office of Ireland Cuid I Paitinní agus Dearachtaí No. 2428 Wednesday, 6 January, 2021 NOTE: The office does not guarantee the accuracy of its publications nor undertake any responsibility for errors or omissions or their consequences.
    [Show full text]
  • 2018 Annual Report
    2018 Annual Report Danaher 2018 Annual Report Financial Operating Highlights (dollars in millions except per share data and number of associates) 2018 2017 Sales $ 19,893.0 $ 18,329.7 Operating Profit $ 3,403.8 $ 2,990.4 Net Earnings $ 2,650.9 $ 2,469.8 Net Earnings Per Share (diluted) $ 3.74 $ 3.50 Operating Cash Flow $ 4,022.0 $ 3,477.8 Investing Cash Flow $ (2,949.4) $ (843.4) Financing Cash Flow $ (797.4) $ (3,098.5) Capital Expenditures $ (655.7) $ (619.6) Capital Disposals $ 6.3 $ 32.6 Free Cash Flow (Operating Cash Flow less Capital Expenditures plus Capital Disposals) $ 3,372.6 $ 2,890.8 Number of Associates 71,000 67,000 Total Assets $ 47,832.5 $ 46,648.6 Total Debt * $ 9,740.3 $ 10,522.1 Stockholders’ Equity $ 28,226.7 $ 26,367.8 Total Capitalization (Total Debt plus Stockholders’ Equity) $ 37,967.0 $ 36,889.9 * Long-Term Debt ($9,688.5 for 2018 and $10,327.4 for 2017) plus Notes Payable and Current Portion of Long-Term Debt ($51.8 for 2018 and $194.7 for 2017) All financial data set forth in this annual report relates solely to continuing operations unless otherwise indicated. 2018 Annual Report Dear Shareholders, As I begin my 30th year at Danaher, it is humbling to reflect on what our team has achieved over that time and exciting to think about the opportunities that still lie ahead. Financially and strategically, 2018 was an outstanding year. With the Danaher Business System (DBS) as our driving force, we strengthened our footholds in attractive, fast-growing markets and enhanced our competitive positions.
    [Show full text]
  • Corporation 1998 Annual Report
    Danaher Corporation 1998 Annual Report 1 About the Cover: Our 1997 annual report cover depicted a “swift-flowing” river – the origin and inspiration of our company and the Danaher name. This year, our 1998 cover features a team of Fluke associates negotiating their way down the rapids of Colorado’s Arkansas River. The Fluke Corporation was acquired by Danaher in July 1998. Teams of Fluke associates make regular trips to the Royal Gorge to enjoy the excitement, challenge, natural beauty and camaraderie of white-water rafting. Just as these individuals are shown steering their way through a turbulent passage, Danaher in 1998 also experienced a challenging operating environ- ment. Despite the white water around us, we ended the year with record results and momentum for the future. Danaher Corporation Danaher Corporation designs, manufactures and markets industrial and consumer products with strong brand names, proprietary technology and major market positions in two principal businesses: Process/Environmental Controls and Tools and Components. Through a focused strategy, Danaher has become a leading manufacturer, competing effectively on a global basis by leveraging product value, quality and customer service. Today, Danaher’s 18,000 associates are located in more than 20 countries around the world. Contents Financial Highlights 1 Letter to Shareholders 2 Danaher Business Segments 5 Company Overviews 6 Financial Section 12 Management and Directors 30 Shareholders’ Information inside back cover 2 1 Financial Highlights (000’s omitted, except
    [Show full text]
  • Wes Pringle | Senior Vice President Fortive Field Solutions, Fluke President FIELD SOLUTIONS OVERVIEW
    Fortive 2018 Investor Day June 12, 2018 FORWARD-LOOKING STATEMENTS & NON-GAAP FINANCIAL MEASURES Statements in this presentation that are not strictly historical, statements regarding the Company's anticipated earnings, business and acquisition opportunities, anticipated revenue growth, anticipated operating margin expansion, anticipated cash flow, economic conditions, future prospects, the proposed acquisition of Advanced Sterilization Products business (“ASP”), the pending transactions with Altra Industrial Motion and any other statements identified by their use of words like “anticipate,” “expect,” “believe,” “outlook,” “guidance,” or “will” or other words of similar meaning are “forward- looking” statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things: deterioration of or instability in the economy, the markets we serve and the financial markets, contractions or lower growth rates and cyclicality of markets we serve, competition, changes in industry standards and governmental regulations, our ability to successfully identify, consummate, integrate and realize the anticipated value of appropriate acquisitions and successfully complete divestitures and other dispositions, our ability to develop and successfully market
    [Show full text]
  • Envista Holdings Corp NVST
    14 October 2019 Equity Research Americas | United States Envista Holdings Corp NVST Bracing for Growth; Initiate Neutral; $30 Target Price Target price (12M, US$) 30.00 [V] Life Science Tools and Diagnostics | Initiation Neutral ■ Initiate Neutral; $30 Target Price: As a leading global manufacturer of dental, NVST is Price (11 Oct 19, US$) 27.93 levered to a seemingly stabilizing underlying dental industry backdrop, where it supports 52-week price range 29.07 - 26.59 90% of practitioners’ clinical needs. We expect earnings growth to accelerate on dedicated Market cap (US$ m) 4,431.13 innovation efforts, greater penetration in high-growth markets, and efficiency initiatives as a Enterprise value (US$ m) 5,650.91 [V] = Stock Considered Volatile (see Disclosure Appendix) more nimble standalone entity, as the recent spinoff of Danaher’s Dental segment. All in, these drivers should accelerate organic revenue growth to +low to mid-single digits over the next five years, with earnings growing at a +7% CAGR from 2019E-2023E. Research Analysts ■ Positioning for Growth via Targeted Innovation: While dental demand trends have Erin Wilson Wright been lackluster over the past few years, we view rising dental utilization stemming from 212 538 4080 favorable demographics, an emphasis on aesthetic and preventative care, along with [email protected] expanding adoption of digital dentistry should drive improving demand for dental Katie Tryhane consumables and equipment long term. For NVST, reinvigorated innovation, focused on 212 325 2713 Specialty products (i.e. N1 Implants, Spark Clear Aligners), an inherently faster growing [email protected] category (48% of sales), should spur growth, alongside efforts to fortify Dental Support Org.
    [Show full text]
  • 2012 Annual Report 1 Table of Contents
    2012 ANNUAL REPORT 1 TABLE of CONTENTS Environmental 2 Test & Measurement 4 Dental 6 Life Sciences & Diagnostics 8 Industrial Technologies 10 Letter to the Shareholders 12 2012 Form 10-K 16 Supplemental Financial Information 141 Directors & Executive Officers 143 Shareholder Information 144 DANAHER FINANCIAL OPERATING HIGHLIGHTS (dollars in millions, except per share data and number of associates) 2012 2011 Sales* $ 18,260.4 $ 16,090.5 Operating Profit* $ 3,165.1 $ 2,617.2 Net Earnings* $ 2,299.3 $ 1,935.3 Earnings per share (diluted)* $ 3.23 $ 2.77 Operating Cash Flow* $ 3,502.1 $ 2,732.1 Capital Expenditures* $ 458.3 $ 334.5 Free Cash Flow (operating cash flow less capital expenditures)* $ 3,043.8 $ 2,397.6 Number of Associates 63,000 59,000 Total Assets $ 32,941.0 $ 29,949.5 Total Debt $ 5,343.1 $ 5,305.2 Stockholders’ Equity $ 19,083.9 $ 16,971.8 Total Capitalization (total debt plus stockholders’ equity) $ 24,427.0 $ 22,277.0 *from continuing operations Environmental We provide products that help protect our water supply and air quality by serving two primary markets: water quality and retail/commercial petroleum. Our water quality business provides instrumentation and disinfection systems to help analyze and manage the quality of ultra- pure, potable, waste, ground and ocean water in residential, commercial, industrial and natural resource applications. Our retail/commercial petroleum business is a leading worldwide provider of solutions and services focused on fuel dispensing, remote fuel management, point-of- sale systems, payment systems and environmental compliance. 3 Test & Measurement We are a global provider of electronic measurement instruments, professional test tools, thermal imaging and calibration equipment used in electrical and industrial applications.
    [Show full text]
  • VONTIER CORPORATION (Exact Name of Registrant As Specified in Its Charter)
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________ FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 x For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-39483 ________________________________________________ VONTIER CORPORATION (Exact name of registrant as specified in its charter) Delaware 84-2783455 (State or other jurisdiction of (I.R.S. employer incorporation or organization) identification number) 5438 Wade Park Boulevard, Suite 600 Raleigh, NC 27607 (Address of principal executive offices, including zip code) Registrant’s telephone number, including area code: (984) 247-8308 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol Name of each exchange on which registered Common stock, par value $0.0001 per share VNT New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer as defined in Rule 405 of the Securities Act. Yes o No x Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • Fortive Corporation Annual Report 2019
    Fortive Corporation Annual Report 2019 Form 10-K (NYSE:FTV) Published: February 28th, 2019 PDF generated by stocklight.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________ FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-37654 ________________________________________________ FORTIVE CORPORATION (Exact name of registrant as specified in its charter) Delaware 47-5654583 (State or Other Jurisdiction of (I.R.S. Employer Incorporation or Organization) Identification Number) 6920 Seaway Blvd Everett, WA 98203 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number, including area code: (425) 446 - 5000 Securities Registered Pursuant to Section 12(b) of the Act: Title of Each Class Name of Each Exchange On Which Registered Common Stock $.01 par value New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: NONE (Title of Class) Indicate by check mark if the registrant is a well-known seasoned issuer as defined in Rule 405 of the Securities Act. Yes x No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • EU Top Applicants 2010-2014 Based on Assignees2014 5Yr.Tsv
    EU top applicants 2010-2014 Based on Assignees2014 5yr.tsv table_row ordering_cd 15943 309 13406 105 13407 105 13408 105 13409 105 13410 105 13411 105 13412 105 13413 105 13414 105 13415 105 13416 105 13417 105 13418 105 13419 105 13420 105 13421 105 13422 105 13423 105 13424 105 Page 1 of 1235 09/26/2021 EU top applicants 2010-2014 Based on Assignees2014 5yr.tsv st_country_cd us_or_foreign FRX (Foreign) ATX (Foreign) ATX (Foreign) ATX (Foreign) ATX (Foreign) ATX (Foreign) ATX (Foreign) ATX (Foreign) ATX (Foreign) ATX (Foreign) ATX (Foreign) ATX (Foreign) ATX (Foreign) ATX (Foreign) ATX (Foreign) ATX (Foreign) ATX (Foreign) ATX (Foreign) ATX (Foreign) ATX (Foreign) Page 2 of 1235 09/26/2021 EU top applicants 2010-2014 Based on Assignees2014 5yr.tsv state_country_of_origin assignee_name FRANCE IMERJ, LTD. AUSTRIA INFINEON TECHNOLOGIES AG AUSTRIA ~INDIVIDUALLY OWNED PATENT AUSTRIA AMS AG AUSTRIA NXP B.V. AUSTRIA JULIUS BLUM GMBH AUSTRIA BAXTER INTERNATIONAL INC. AUSTRIA EPCOS AG AUSTRIA INFINEON TECHNOLOGIES AUSTRIA AG AUSTRIA MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH AUSTRIA SIEMENS AKTIENGESELLSCHAFT AUSTRIA AVL LIST GMBH AUSTRIA MAGNA POWERTRAIN AG & CO KG AUSTRIA HILTI AKTIENGESELLSCHAFT AUSTRIA BOEHRINGER INGELHEIM INTERNATIONAL GMBH AUSTRIA FRONIUS INTERNATIONAL GMBH AUSTRIA SIEMENS VAI METALS TECHNOLOGIES GMBH AUSTRIA CONTINENTAL AUTOMOTIVE GMBH AUSTRIA INTEL MOBILE COMMUNICATIONS GMBH AUSTRIA MAGNA STEYR FAHRZEUGTECHNIK AG & CO. KG Page 3 of 1235 09/26/2021 EU top applicants 2010-2014 Based on Assignees2014 5yr.tsv CY_2010 CY_2011
    [Show full text]